BioCentury
ARTICLE | Clinical News

Fluasterone synthetic steroid data

March 16, 1998 8:00 AM UTC

Aeson said results of its Swiss Phase I trial with fluasterone in healthy volunteers showed that the product is safe at high doses and not metabolized to testosterone or estrogen in men or women.

A total of 36 subjects were given a single dose of 100-1600 mg daily for 14 days, compared to 10 subjects on placebo. A total of 12 subjects were given a multiple dose of either 400 mg or 800 mg twice a day for 14 days, compared to 2 on placebo. ...